Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Italchimici is an Italian pharmaceutical company specializing in the development and commercialization of therapeutic products across several key areas, including gastroenterology, respiratory health, and dermatology. Founded in 1963 and headquartered in Milan, the company established a strong presence in the Italian mid-market with a portfolio of well-known brands such as Reuflor and Peridon. In 2016, Italchimici was acquired by the international pharmaceutical group Recordati for an enterprise value of €130 million. Today, it operates as a subsidiary of Recordati, continuing to provide established medical solutions and over-the-counter (OTC) products to the healthcare market. The company's business model focuses on leveraging a specialized sales force to promote high-quality treatments to specialists and general practitioners throughout Italy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Italchimici.